Jin Medical International Ltd (ZJYL) Inventory Turnover Ratio, from fourth quarter 2025 to fourth quarter 2023, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Jin Medical International Ltd  (ZJYL)
 

Jin Medical International Ltd Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the fourth quarter 2025, Jin Medical International Ltd's inventory turnover ratio sequentially decreased to 5.03 in the fourth quarter 2025, unsurprisingly, as the Jin Medical International Ltd markets continue to deteriorate, and ZJYL's faces growing challenges to bring down its inventories. Jin Medical International Ltd's average inventory processing period in the Sep 30 2025 quarter, has increased to 73 days, from 57 days, in the 0 quarter.

Within Healthcare sector 19 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form in the third quarter 2025, to 1201.

ZJYL Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Jin Medical International Ltd Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ZJYL Inventory Turnover Ratio (Sep 30 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Sep 30 2023)
IV. Quarter
Y / Y Inventory Growth 260.03 % 119.38 % -2.57 % 8.28 % -72.94 %
Y / Y Cost of Sales Growth 12.32 % - - - -
Inventory Turnover Ratio (TTM) 5.03 - - - 6.81
ZJYL's Total Ranking # 1201 # # # #
Average inventory processing period 73 - - - 54
Seq. Inventory Growth 437.56 % -81.4 % 453.85 % -34.99 % 227.55 %
Seq. Cost of Sales Growth - - - - -




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 5
Healthcare Sector # 20
Overall Market # 1201

Inventory Turnover Ratio Statistics
High Average Low
15.77 12.97 10.16
(Sep 30 2025)   (Sep 30 2024)



ZJYL Company Profile >> Back to ZJYL Efficiency Comparisons >> Compare ZJYL Inventory Turnover Ratio to its Competitors

Financial Statements
Jin Medical International Ltd's Inventories $ 5 Millions Visit ZJYL's Balance sheet
Jin Medical International Ltd's Cost of Revenues TTM $ 15 Millions Visit ZJYL's Income Statement
What are ZJYL's Sales? Visit ZJYL's Sales by Segment

Other Inventory Turnover Ratios
Jin Medical International Ltd's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ZJYL's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ZJYL's Competitors
Inventory Turnover Ratio for ZJYL's Suppliers
Inventory Turnover Ratio for ZJYL's Customers

You may also want to know
ZJYL's Sales Growth Rates ZJYL's Pe Price to earnings ratio ZJYL's Receivables Turnover Ratio ZJYL's Stock Quote
ZJYL's Net Income Growth Rates ZJYL's Ps Price to Sales ratio ZJYL's Sales per Employee ZJYL's Asset Turnover Ratio
ZJYL's Net Margin ZJYL's Pb Price to Book ratio ZJYL's Financial Strength Ratios ZJYL's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2025, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2025 Inventories at quarter ending Sep 30 2025
Warby Parker Inc   8.16 $ 387.000  Millions$ 47  Millions
Adaptive Biotechnologies Corporation  8.03 $ 71.180  Millions$ 9  Millions
Semler Scientific inc   7.71 $ 3.413  Millions$ 0  Millions
Opko Health Inc   7.70 $ 485.347  Millions$ 63  Millions
Inogen Inc   7.63 $ 191.710  Millions$ 25  Millions
Tarsus Pharmaceuticals Inc   7.57 $ 24.683  Millions$ 3  Millions
Twist Bioscience Corporation  7.48 $ 185.570  Millions$ 25  Millions
Universe Pharmaceuticals Inc  7.19 $ 11,557.563  Millions$ 1,608  Millions
Alnylam Pharmaceuticals Inc   7.04 $ 512.092  Millions$ 73  Millions
Fonar Corporation  6.98 $ 19.414  Millions$ 3  Millions
Neuraxis Inc   6.94 $ 0.561  Millions$ 0  Millions
Lucid Diagnostics Inc   6.86 $ 3.114  Millions$ 0  Millions
Kewaunee Scientific Corporation  6.55 $ 203.000  Millions$ 31  Millions
Carlisle Companies Incorporated  6.44 $ 3,197.600  Millions$ 496  Millions
Scorpius Holdings inc   6.44 $ 1.303  Millions$ 0  Millions
Charles River Laboratories International inc   6.12 $ 1,761.939  Millions$ 288  Millions
Vanda Pharmaceuticals Inc   6.01 $ 11.801  Millions$ 2  Millions
Adm Tronics Unlimited Inc   5.82 $ 2.047  Millions$ 0  Millions
Bionexus Gene Lab Corp   5.82 $ 6.967  Millions$ 1  Millions
Avantor Inc   5.75 $ 4,396.800  Millions$ 764  Millions
Hims and Hers Health Inc   5.68 $ 551.000  Millions$ 97  Millions
Moderna Inc   5.65 $ 1,155.000  Millions$ 204  Millions
Scilex Holding Company  5.60 $ 12.676  Millions$ 2  Millions
Phathom Pharmaceuticals Inc   5.60 $ 18.767  Millions$ 3  Millions
Exact Sciences Corporation  5.57 $ 940.831  Millions$ 169  Millions
Harrow Inc   5.55 $ 63.601  Millions$ 11  Millions
Puma Biotechnology Inc   5.51 $ 48.951  Millions$ 9  Millions
Veracyte Inc   5.47 $ 125.021  Millions$ 23  Millions
Bristol myers Squibb Company  5.47 $ 14,652.000  Millions$ 2,680  Millions
Transmedics Group Inc   5.19 $ 224.949  Millions$ 43  Millions

Date modified: 2026-07-07T14:09:45+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.